Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Sitek

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|January 9, 2019
A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded VpxChristine D Landsberg, Dominik A Megger, Dominik Hotter, et al.
Redox Biology|May 22, 2022
An increase in surface hydrophobicity mediates chaperone activity in N-chlorinated RidAMarharyta Varatnitskaya, Julia Fasel, Alexandra Müller, et al.
Cardiovascular Research|May 18, 2017
Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibitionBarbara Kutryb-Zajac, Lukasz Mateuszuk, Paulina Zukowska, et al.
Journal of Proteome Research|December 3, 2015
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular CarcinomaWael Naboulsi, Dominik A Megger, Thilo Bracht, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2015
Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and PharmacokineticsKamil Kus, Maria Walczak, Edyta Maslak, et al.
Digestive Diseases and Sciences|February 1, 2014
Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disordersAlexander Baraniskin, Stefanie Nöpel-Dünnebacke, Brigitte Schumacher, et al.
Redox Biology|October 13, 2017
Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery diseaseMiriam M Cortese-Krott, Evanthia Mergia, Christian M Kramer, et al.
Journal of Proteome Research|August 29, 2009
Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validationBarbara Sitek, Bence Sipos, Ibrahim Alkatout, et al.
Molecular & Cellular Proteomics : MCP|March 7, 2013
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics studyDominik A Megger, Thilo Bracht, Michael Kohl, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 9, 2016
MFAP4: a candidate biomarker for hepatic and pulmonary fibrosis?Christian Mölleken, Gereon Poschmann, Francesco Bonella, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|January 9, 2019
A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded VpxChristine D Landsberg, Dominik A Megger, Dominik Hotter, et al.
Redox Biology|May 22, 2022
An increase in surface hydrophobicity mediates chaperone activity in N-chlorinated RidAMarharyta Varatnitskaya, Julia Fasel, Alexandra Müller, et al.
Cardiovascular Research|May 18, 2017
Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibitionBarbara Kutryb-Zajac, Lukasz Mateuszuk, Paulina Zukowska, et al.
Journal of Proteome Research|December 3, 2015
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular CarcinomaWael Naboulsi, Dominik A Megger, Thilo Bracht, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 15, 2015
Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and PharmacokineticsKamil Kus, Maria Walczak, Edyta Maslak, et al.
Digestive Diseases and Sciences|February 1, 2014
Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disordersAlexander Baraniskin, Stefanie Nöpel-Dünnebacke, Brigitte Schumacher, et al.
Redox Biology|October 13, 2017
Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery diseaseMiriam M Cortese-Krott, Evanthia Mergia, Christian M Kramer, et al.
Journal of Proteome Research|August 29, 2009
Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validationBarbara Sitek, Bence Sipos, Ibrahim Alkatout, et al.
Molecular & Cellular Proteomics : MCP|March 7, 2013
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics studyDominik A Megger, Thilo Bracht, Michael Kohl, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 9, 2016
MFAP4: a candidate biomarker for hepatic and pulmonary fibrosis?Christian Mölleken, Gereon Poschmann, Francesco Bonella, et al.
Pageof 14